The Hormone Zone & The Longevity Protocol utilizes hundreds of biomarkers and specialty testing to provide the most comprehensive medical analysis available.
Your labs tell a story. If you know how to interpret the story. Conventional “normal” ranges are designed to catch disease. A functional and longevity approach looks for patterns earlier—before symptoms become diagnoses—so we can optimize energy, metabolism, hormones, inflammation, recovery, and longevity.
The Goal? Identify trends, correct deficiencies/excesses, and reduce long-term risk.
Specialty Testing
Specialty testing goes beyond standard labs to uncover root causes and guide personalized care. We offer advanced assessments including Vibrant Wellness Total Tox Burden, Food Reactivity through ImmunoLabs, salivary cortisol testing for adrenal rhythm, and genomic testing with New Amsterdam Genomics. We also provide REMS Bone Health Scans and the Galleri test for proactive, comprehensive health screening.
In-Office Biomarkers
In-office biomarkers provide real-time insight into cardiovascular, metabolic, thyroid, nutrient, and cognitive health. We offer testing such as Nitric Oxide for vascular function, Zinc Tally for functional zinc status, InBody 570 for body composition and visceral fat tracking, ThyroFlex for thyroid screening, SphygmoCor for central blood pressure and arterial stiffness, and CNS Vital Signs to establish and monitor cognitive performance baselines.
Blood Lab Testing
Our comprehensive blood lab testing provides functional interpretation and early pattern recognition. We evaluate everything from CBC and metabolic panels to advanced hormone testing, thyroid, adrenal, metabolic, inflammatory, and more. By analyzing optimal ranges, trend patterns, and root-cause clues, we personalize prevention and treatment strategies based on physiology, not just reference intervals.
Specialty Testing
Vibrant Wellness Total Tox Burden
Assesses patterns of environmental exposures; used to guide detoxification and prevention strategies.
Food Reactivity (ImmunoLabs)
Identifies immune reactivity trends to foods; best used alongside symptom tracking and structured elimination/reintroduction.
Adrenal Stress Index (Salivary Cortisol)
Evaluates cortisol rhythm across the day (morning → afternoon → evening) for fatigue, sleep, stress resilience patterns.
Genomic Testing (New Amsterdam Genomics)
Assesses genetic pathways that influence metabolism, detoxification, methylation, inflammation, and personalized prevention.
Advanced and highly accurate bone scan called Radiofrequency Echographic Multi Spectrometry (REMS) which represents a breakthrough in osteoporosis assessment, offering a radiation-free alternative to traditional DEXA scanning.
Galleri- Multi-Cancer Early Detection Test
Galleri is a breakthrough test that identifies cancer-associated DNA signals circulating in your bloodstream.
In-Office Biomarkers
Nitric Oxide
Supports vascular health assessment; often used as a performance/endothelial function marker.
Zinc Tally
Functional assessment of zinc status (often used to guide supplementation strategy).
InBody 570 (Body Composition + Visceral Fat)
Tracks lean mass, fat mass, hydration, and visceral fat trends—key for metabolic risk.
ThyroFlex test
In-office screening tool for thyroid-related signs (used as a complement, not a replacement for lab testing).
SphygmoCor Central Blood Pressure
Measures central (aortic) pressure and arterial stiffness—useful for cardiovascular risk refinement.
CNS Vital Signs Cognitive Testing
Tracks memory, attention, processing speed, and executive function to establish a cognitive baseline and monitor change.
Complete Blood Count (CBC) — Functional Interpretation
What this panel evaluates:
Oxygen delivery, immune balance, inflammation signals, nutrient status (iron/B12/folate), clotting ability.
WBC
4.5–7.5 x10³/µL
High: inflammation/infection/stress; Low: immune suppression/nutrient issues
Neutrophils %
45–65%
High: acute stress/infection; Low: viral trends
Lymphocytes %
25–45%
High: viral/immune activation; Low: stress/cortisol effect
Monocytes %
4–9%
High: chronic inflammation, recovery phase
Eosinophils %
0–4%
High: allergies/asthma/parasite patterns
Basophils %
0–1%
High: allergic/inflammatory signals
RBC
♀ 4.2–5.0 / ♂ 4.5–5.5 M/µL
Low: anemia patterns; High: dehydration/altitude/testosterone effect
Hemoglobin
♀ 13.0–14.5 / ♂ 14.0–16.5 g/dL
Low: anemia/iron/B12/folate; High: thick blood risk
Hematocrit
♀ 38–44% / ♂ 41–49%
Tracks hydration, oxygen capacity
MCV
84–92 fL
High: B12/folate/thyroid; Low: iron deficiency
MCH
28–32 pg
Low: iron deficiency trend
MCHC
32–35 g/dL
Low: iron deficiency/hypochromia
RDW
11.5–13.0%
High: mixed deficiencies, inflammation, higher risk marker
Platelets
180–320 x10³/µL
High: inflammation/iron deficiency; Low: bleeding risk patterns
Functional pattern clues (quick reads)
Low MCV + high RDW → iron deficiency trend
High MCV → B12/folate deficiency, thyroid slowing, alcohol pattern
High platelets + low ferritin → classic iron deficiency signature
Chemistry / Metabolic Panel (CMP) — Functional Interpretation
What this panel evaluates:
Liver & kidney function, electrolytes, protein status, blood sugar, hydration, acid-base balance.
Glucose (fasting)
75–90 mg/dL
High: insulin resistance; Low: reactive hypoglycemia trend
BUN
10–16 mg/dL
High: dehydration/high protein; Low: low protein/liver issues
Creatinine
0.7–1.1 mg/dL
Context = muscle mass + kidney filtration
eGFR
≥ 90
Lower: reduced kidney filtration (age-adjusted context)
Sodium
138–142 mmol/L
Low: adrenal/overhydration; High: dehydration
Potassium
4.0–4.7 mmol/L
Low/high: adrenal, kidney, meds, arrhythmia risk
Chloride
101–106 mmol/L
Acid-base/hydration clues
CO₂ (bicarb)
24–28 mmol/L
Low: metabolic acidosis; High: alkalosis
Calcium
9.2–10.0 mg/dL
Needs albumin + PTH/Vit D context
Total Protein
6.8–7.6 g/dL
Low: low intake/absorption; High: inflammation
Albumin
4.2–4.8 g/dL
Low: inflammation/liver; High: dehydration
Globulin
2.2–3.2 g/dL
Immune/inflammation marker
A/G ratio
1.4–2.2
Low: inflammation; High: low globulins
Bilirubin (total)
0.4–1.0 mg/dL
Detox/bile flow, Gilbert’s context
ALP
55–90 U/L
High: bile/bone; Low: zinc deficiency trend
AST
10–26 U/L
High: liver/muscle; interpret with ALT/CK
ALT
10–26 U/L
High: fatty liver/metabolic stress
ABO Blood Typing
What it tells you: Your blood group (A, B, AB, O) and Rh factor (±).
Use: transfusion safety, pregnancy compatibility, medical records.
Sex Hormone Panel for Women
(Optimal ranges vary by cycle phase & whether on hormone therapy.)
Estradiol (E2)
- Follicular: 30–80 pg/mL
- Ovulation peak: 150–400 pg/mL
- Luteal: 80–250 pg/mL
- Post-menopause: 50 to 150 pg/mL (Optimal Replacement Range)
- Too low: dryness, sleep issues, bone loss; Too high: heavy cycles, breast tenderness, water retention.
Estrone (E1)
- 2:1 ratio of E2:E1 is optimal
- Often tracks: adipose-driven estrogen and conversion patterns.
FSH
- Follicular: 3–10 mIU/mL
- Perimenopause: rising/variable
- Post-menopause: <20 is the Optimal Replacement Range
- Higher suggests: ovarian reserve decline / menopause transition.
Testosterone
- Total: 70-150 ng/dL (functional target)
- Low: low libido/energy; High: acne/hair growth/PCOS pattern.
Progesterone
- Luteal (mid-luteal optimal): 10–20 ng/mL
- Follicular: <1 ng/mL
- Low luteal progesterone → PMS, anxiety, sleep disruption, spotting.
Sex Hormone Panel for Men
Total Testosterone
Functional optimal: 700–1100 ng/dL (symptom-dependent)
Free Testosterone
Optimal: >25 ng/dL (or lab-specific free T upper-middle range)
Estradiol (E2)
Optimal: 20–40 pg/mL
Too low → joint pain/low libido; too high → water retention/mood swings.
Luteinizing Hormone (LH)
Optimal: 2–6 mIU/mL
High LH + low T suggests primary testicular issue; low LH + low T suggests pituitary/hypothalamic pattern.
PSA
Functional target: <4.0 ng/mL (age-adjusted)
Trend over time matters more than one value.
Adrenal Function
Pregnenolone
Optimal: 90–150 ng/dL
Low can correlate with stress depletion, brain fog; high may reflect supplementation or upstream hormone shifts.
DHEA (prefer DHEA-S)
Optimal (age-adjusted): mid–upper third of lab range
General functional target often: >280 for Women >400 for Men
Prolactin
Optimal: 5–15 ng/mL
High can suppress libido/fertility and reflect stress, medications, pituitary signaling.
Insulin & Metabolic Panel
Fasting Blood Sugar
Optimal: 75–90 mg/dL
Fasting Insulin
Optimal: 2–9 µIU/mL
Higher suggests insulin resistance.
Hemoglobin A1C
Optimal: 4.9–5.3%
5.4–5.6 = early drift; ≥5.7 = prediabetes pattern.
Creatine Kinase (CK)
Optimal: ~50–200 U/L (athletes can be higher)
High reflects muscle damage/exertion, statin effects, inflammation.
Lactic Acid
Optimal: 0.5–1.8 mmol/L
High can reflect poor oxygen utilization, mitochondrial stress, acute illness/exertion.
Complete Lipid Panel
Functional targets
- Triglycerides: <100 mg/dL
- HDL: ≥60 mg/dL
- LDL-C: individualized risk-based target
ApoB
Functional targets (risk-based):
- <80 mg/dL (lower if very high risk)
- ApoB >130 mg/dL is commonly referenced as a risk-enhancing factor.
Inflammatory Biomarkers
ESR (Sed Rate)
Optimal: 0–10 mm/hr
Higher suggests chronic inflammation.
Homocysteine
Optimal: <8 µmol/L
High can reflect low B12/folate/B6 needs, methylation burden, vascular risk.
Uric Acid
Optimal: Men 4.0–6.0 / Women 3.5–5.5 mg/dL
High often tracks insulin resistance and gout risk.
CRP (prefer hs-CRP)
Optimal: <1.0 mg/L
Risk categories commonly used: <1 low, 1–3 moderate, >3 high.
Ferritin
Optimal (functional): 50–150 ng/mL
Low = iron deficiency trend; high may reflect inflammation or iron overload—interpret with iron saturation and CRP.
Thyroid Panel Comprehensive
TSH
Functional optimal: 0.8–2.0 mIU/L (symptom-dependent)
Many labs list normal roughly ~0.4 to 4–5.5.
Free T3
Optimal: Upper third of lab range (often ~3.2–4.2 pg/mL, lab-dependent)
Free T4
Optimal: Upper half of lab range (often ~1.2–1.5 ng/dL, lab-dependent) d)
Total T4
Optimal: > 7 (binding protein dependent)
Reverse T3
Optimal: < 11 ng/dL High can reflect stress/illness/calorie restriction impacting conversion.
Thyroglobulin Antibodies (TgAb)
Optimal: Negative
Thyroid Peroxidase Antibodies (TPOAb)
Optimal: Negative
TSI (Thyroid Stimulating Immunoglobulins)
Optimal: Negative Positive suggests Graves’-type stimulating autoimmunity.
Nutritional Markers
Vitamin D (25-OH)
Optimal: 50–70 ng/mL
RBC Zinc
Optimal: mid–upper lab range (commonly ~10–14 mg/L, lab-dependent)
RBC Magnesium
Optimal: upper half of lab range (often ~5.5–6.5 mg/dL, lab-dependent)
Cardio IQ OmegaCheck
Common functional targets
- Omega-3 Index: 8–12%
- AA/EPA ratio: lower is generally better (often <10, ideally lower)
Methylmalonic Acid (MMA)
Optimal: <0.20 µmol/L
Higher suggests functional B12 deficiency trend.
Folate
Optimal: >20 ng/mL (or RBC folate in upper range)
Iron and Copper Panel
- Total Iron: 75–130 µg/dL
- TIBC: 300–360 µg/dL
- Iron Saturation: 25–40%
- Ferritin: 50–100 ng/mL (context matters)
- Ceruloplasmin: 20–35 mg/dL (low = copper transport issues; high = inflammation/estrogen effect)
- Reticulocyte Count: 0.8–2.0% (or absolute retic per lab)
- Low retic with anemia → iron not reaching marrow
- Rising retic after iron therapy → good response
Longevity Markers
IGF-1
Optimal: age-adjusted midrange (avoid extremes) (>150, <220)
Too low = frailty trend; too high = growth signaling risk pattern.
Spike Protein Antibodies
Reflects immune response to vaccination/infection; interpretation depends on assay and clinical context.
MTHFR Gene Mutation
Helps explain methylation/folate processing tendencies; action is based on labs + symptoms (homocysteine, folate, B12).
GGT
Optimal: < 9 for women, <14 for men U/L
Higher can reflect oxidative stress, fatty liver, alcohol effects, toxin burden.
Cystatin C
Optimal: 0.6–1.0 mg/L
A sensitive kidney filtration marker (less muscle-dependent than creatinine).
Advanced Cancer Screening
Precision Early Detection in Scottsdale, Arizona
Cancer does not begin when it is diagnosed.
It begins silently—at the molecular level, years before symptoms ever appear.
At The Hormone Zone, we do not wait for disease to declare itself.
We identify it early—when intervention is most powerful.
This is the next evolution of screening:
multi-cancer detection + epigenetic intelligence.
The New Standard: Beyond Traditional Screening
Traditional screening is limited:
- It focuses on one cancer at a time
- It often detects disease late in its course
- It relies heavily on imaging and invasive procedures
We utilize advanced blood-based diagnostics that identify cancer earlier, more precisely, and with far greater clarity.
Galleri
Detect Signals from 50+ Cancers—With a Single Blood Draw
Galleri is a breakthrough test that identifies cancer-associated DNA signals circulating in your bloodstream.
What Makes It Different
- Screens for 50+ cancer types simultaneously
- Detects cancers that have no routine screening tests
- Provides tissue-of-origin insight (where the cancer signal is coming from)
- Designed for early-stage detection
Who It’s For
- Adults 40+ focused on longevity
- High-performance individuals seeking proactive screening
- Patients with family history of cancer
- Those who want more than standard screening
Clinical Advantage
This is not replacing traditional screening—it is amplifying it.
It allows us to:
- Identify risk earlier
- Guide targeted imaging
- Avoid unnecessary delays in diagnosis
EpiSwitch PSE
Transforming PSA Into a High-Precision Tool
PSA alone has always been limited—it creates uncertainty, false positives, and unnecessary biopsies.
EpiSwitch PSE changes that.
What It Does
- Uses epigenetic analysis (chromatin conformation signatures)
- Evaluates how prostate cancer genes are functionally expressed
- Integrates with PSA to provide a clear, actionable result
What You Get
- ~94% accuracy in prostate cancer risk assessment
- A binary result:
- Low likelihood
- High likelihood
- Significant reduction in unnecessary biopsies
Who It’s For
- Men with elevated or borderline PSA
- Men 40+ optimizing longevity
- Patients wanting to avoid unnecessary invasive procedures
- High-level executives seeking certainty, not ambiguity
The Power of Combining Both
This is where true cancer intelligence emerges.
Galleri + EpiSwitch Together Provide:
- Whole-body cancer signal detection
- Targeted prostate-specific precision
- Earlier identification across multiple pathways
- A layered, strategic approach to risk
This is not screening—it is predictive oncology applied clinically.
You don’t wait for cancer.
You outmaneuver it.
At The Hormone Zone, we use the most advanced tools available to detect risk early—when you still have control.
Schedule your Advanced Cancer Screening consultation in Scottsdale or Prescott today. Because the future of medicine is not reactive.
It is predictive, precise, and personalized.
